WNK2 and neoplasm: miRNA 167 and miRNA 1525 significantly inhibit mitogen-activated protein kinases (MAPK) and NF-kB signalling pathways in cross-kingdom analysis, indicating that these two miRNAs are likely beneficial for maintaining cell proliferation and angiogenesis and play a role in regulating the tumour microenvironment.